SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000920465-20-000067
Filing Date
2020-05-06
Accepted
2020-05-06 16:02:18
Documents
4
Period of Report
2020-05-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a20208-k06may2020.htm 8-K 30317
2 EXHIBIT 99.1 exhibitfy20tetraphase.htm EX-99.1 6903
3 ljpc8kimages0001.jpg GRAPHIC 21134
4 ljpc8kimages0002.jpg GRAPHIC 6330
  Complete submission text file 0000920465-20-000067.txt   76394
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 20852530
SIC: 2836 Biological Products, (No Diagnostic Substances)